Observe Medical Past Earnings Performance
Past criteria checks 0/6
Observe Medical's earnings have been declining at an average annual rate of -26.3%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been growing at an average rate of 9.4% per year.
Key information
-26.3%
Earnings growth rate
14.7%
EPS growth rate
| Medical Equipment Industry Growth | 4.3% |
| Revenue growth rate | 9.4% |
| Return on equity | -44.4% |
| Net Margin | -163.4% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Observe Medical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 29 | -48 | 18 | 0 |
| 31 Mar 24 | 29 | -54 | 21 | 0 |
| 31 Dec 23 | 28 | -60 | 24 | 0 |
| 30 Sep 23 | 24 | -67 | 26 | 0 |
| 30 Jun 23 | 19 | -69 | 27 | 0 |
| 31 Mar 23 | 18 | -59 | 28 | 0 |
| 31 Dec 22 | 20 | -51 | 27 | 0 |
| 30 Sep 22 | 19 | -46 | 23 | 0 |
| 30 Jun 22 | 23 | -40 | 22 | 0 |
| 31 Mar 22 | 29 | -31 | 19 | 0 |
| 31 Dec 21 | 24 | -26 | 17 | 0 |
| 30 Sep 21 | 23 | -32 | 16 | 0 |
| 30 Jun 21 | 16 | -30 | 13 | 0 |
| 31 Mar 21 | 6 | -41 | 12 | 0 |
| 31 Dec 20 | 3 | -37 | 10 | 0 |
| 30 Sep 20 | 0 | -21 | 9 | 0 |
| 30 Jun 20 | 0 | -19 | 8 | 0 |
| 31 Mar 20 | 0 | -13 | 5 | 0 |
| 31 Dec 19 | 0 | -17 | 4 | 0 |
| 31 Dec 18 | 0 | 2 | 3 | 0 |
Quality Earnings: OM5A is currently unprofitable.
Growing Profit Margin: OM5A is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: OM5A is unprofitable, and losses have increased over the past 5 years at a rate of 26.3% per year.
Accelerating Growth: Unable to compare OM5A's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: OM5A is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (16.2%).
Return on Equity
High ROE: OM5A has a negative Return on Equity (-44.38%), as it is currently unprofitable.